Centrillion Technologies, founded in 2009, is a biomolecular technology company that pioneers high-density DNA chips and the wafer-scale manufacturing systems used to produce them. Based in Palo Alto, California, the company operates at the intersection of advanced manufacturing and synthetic biology.
The firm's products include high-density DNA chips designed to decode genomes, cells, and tissues with precision, supporting applications in spatial biology, genomics, and AI-powered biological analysis. A key performance metric is over 99.9% accuracy in sequencing viral genomes, as demonstrated during the COVID-19 pandemic. Wafer-scale manufacturing systems underpin this production capability.
Centrillion's work spans technical domains such as photolithographic synthesis and programmable probe content. The company serves industry verticals including biotechnology, pharmaceuticals, life sciences, healthcare, and academia.
